| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.06 | 0.2 |